Overview
Takuya Oikawa practices practicing medicine in Kesennuma, Japan.
Mr. Oikawa is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Atrial Fibrillation.
He is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takuya Oikawa
Is Takuya Oikawa a top-rated expert for Heart Failure?
MediFind is an objective health platform that identifies experts based on real-world data. Takuya Oikawa is classified as an Advanced expert for Heart Failure, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takuya Oikawa participate in research or clinical trials?
Yes. Takuya Oikawa has published 18 articles and abstracts on conditions like Heart Failure. You can view a list of Takuya Oikawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Heart FailureMr. Oikawa isAdvanced. Learn about Heart Failure.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Experienced
- Atrial FibrillationMr. Oikawa isExperienced. Learn about Atrial Fibrillation.